OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 65 filers reported holding OCULAR THERAPEUTIX INC in Q1 2016. The put-call ratio across all filers is 0.22 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $852,000 | -23.6% | 172,100 | +7.6% | 0.00% | -100.0% |
| Q4 2021 | $1,115,000 | -22.2% | 160,000 | +11.7% | 0.00% | 0.0% |
| Q3 2021 | $1,433,000 | -28.4% | 143,300 | +1.6% | 0.00% | 0.0% |
| Q2 2021 | $2,001,000 | -12.0% | 141,100 | +1.8% | 0.00% | -50.0% |
| Q1 2021 | $2,274,000 | -19.9% | 138,600 | +1.1% | 0.00% | 0.0% |
| Q4 2020 | $2,838,000 | +2066.4% | 137,100 | +621.6% | 0.00% | – |
| Q3 2016 | $131,000 | +39.4% | 19,000 | 0.0% | 0.00% | – |
| Q2 2016 | $94,000 | -39.7% | 19,000 | +13.1% | 0.00% | – |
| Q1 2016 | $156,000 | +27.9% | 16,800 | +29.2% | 0.00% | – |
| Q4 2015 | $122,000 | -33.3% | 13,000 | 0.0% | 0.00% | – |
| Q3 2015 | $183,000 | -19.4% | 13,000 | +20.4% | 0.00% | -100.0% |
| Q2 2015 | $227,000 | – | 10,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 5,618,424 | $46,801,000 | 100.00% |
| Opaleye Management Inc. | 5,984,200 | $49,848,000 | 10.07% |
| DELTEC ASSET MANAGEMENT LLC | 2,330,267 | $19,411,000 | 4.06% |
| Corriente Advisors, LLC | 720,000 | $5,998,000 | 3.89% |
| Versant Venture Management, LLC | 2,215,384 | $18,454,145,000 | 2.65% |
| SV Health Investors, LLC | 312,068 | $2,600,000 | 1.80% |
| Ikarian Capital, LLC | 2,055,977 | $17,126,000 | 1.36% |
| EAM Global Investors LLC | 265,316 | $2,210,000 | 0.99% |
| EAM Investors, LLC | 346,075 | $2,883,000 | 0.64% |
| RA Capital Management | 2,727,272 | $22,718,000 | 0.44% |